Is Phio Pharmaceuticals Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Phio Pharmaceuticals Corp (PHIO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Phio Pharmaceuticals Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Phio Pharmaceuticals Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Phio Pharmaceuticals Corp?

Muslim investors may consider investing in Phio Pharmaceuticals Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Phio Pharmaceuticals Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Phio Pharmaceuticals Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Phio Pharmaceuticals Corp updated?

The Shariah compliance status of Phio Pharmaceuticals Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Phio Pharmaceuticals Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Phio Pharmaceuticals Corp?

You can check the latest Shariah compliance status of Phio Pharmaceuticals Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PHIO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 10, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Phio Pharmaceuticals Corp (PHIO)

Based on 7 analysts giving stock ratings to Phio Pharmaceuticals Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Phio Pharmaceuticals Corp. Stock Analysis PHIO

United States Health Care Nano Cap Report: 2025 Annual

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company is headquartered in King Of Prussia, Pennsylvania and currently employs 6 full-time employees. The company went IPO on 2012-05-10. The firm's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The company is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. The firm's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.

Key Statistics of Phio Pharmaceuticals Corp (PHIO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.05$1.12

Today's Open

$1.10

Volume

228.66K

P/E Ratio (TTM)

52 Week Range

$0.81$4.19

Market Cap

13.13M

Avg. Volume

145.69K

Dividend Yield

Financial Metrics & Statements of Phio Pharmaceuticals Corp (PHIO)

FAQ's for Phio Pharmaceuticals Corp (PHIO)

According to Musaffa’s Shariah screening methodology, Phio Pharmaceuticals Corp (PHIO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.